Abbott announced today that a team including its scientists has uncovered a rare group of Democratic Republic of Congo residents who are HIV positive but have almost nonexistent viral loads without using antiretroviral treatments. This group of “HIV elite controllers” opens up a new area for researchers to discover biological trends that could inform the […]
iRhythm’s revenue jumps 33% in Q4
iRhythm Technologies (NASDAQ: IRTC) reported mixed Q4 results but predicted strong sales growth in 2021. The San Francisco–based company — maker of the Zio ambulatory cardiac monitoring patch — reported a loss of –$9.7 million, or –33¢ per share, on sales of $78.8 million for the three months ended Dec. 31, 2020, nearly halving its […]
Terumo to acquire Health Outcomes Sciences
Terumo (TSE: 4543) recently announced that it has signed a definitive agreement to acquire all assets of Health Outcomes Sciences. The financial terms of the deal were not disclosed. Phoenix-based HOS is a creator of predictive analytics and clinical decision support software. Its sePRISM content enablement platform is meant to enable healthcare organizations to deliver […]
NuVasive reports mixed Q4 results
NuVasive (NASDAQ: NUVA) today reported Q4 earnings that beat the consensus forecast on Wall Street, but it came up short on revenue. The San Diego–based spine tech company earned $1.7 million, or 3¢ per share, on sales of $291.8 million for the three months ended Dec. 31, 2020, for a bottom-line drop of –94% on […]
Stereotaxis up on Street-beating Q4 results
Shares of Stereotaxis (NYSE:STXS) shot up in morning trading today after the robotic surgery company reported Street-beating Q4 results and predicted double-digit revenue growth this year. The St. Louis–based company, creator of robotic technologies for the treatment of cardiac arrhythmias, reported a loss of –$1.18 million, or –2¢ share, on sales of $6.82 million for the […]
Nevro posts Street-beating Q4 results
Nevro (NYSE:NVRO) posted fourth-quarter results that beat the consensus forecast on Wall Street as it issued 2021 guidance that was slightly below analysts’ expectations. The Redwood City, Calif.–based spinal cord stimulation system maker reported a loss of –$7.2 million, or –21¢ per share, on sales of $109.7 million for the three months ended Dec. 31, 2020, […]
Elizabeth Holmes, prosecutors trade accusations over lost evidence
Ex-Theranos CEO Elizabeth Holmes through her lawyers is blaming prosecutors’ “investigative failure” for the loss of a company database that would have shown the level of inaccurate blood-testing results. In a filing yesterday, Holmes’ lawyers claim that in the absence of information in the Laboratory Information System (LIS) database, the judge should not allow jurors […]
Titan Medical brings in another $23 million
Titan Medical (TSX:TMD;OTC:TITFX) today announced the closing of a $23 million bought deal. The Toronto-based surgical robotics company conducted the sale by way of a short form prospectus in each of the provinces of British Columbia, Alberta and Ontario — as well as a private placement in the U.S. Last month, Titan Medical raised an additional […]
Masimo reports a Street-beating Q4
Masimo (NSDQ:MASI) posted fourth-quarter results today that beat the consensus forecast on Wall Street, issuing 2021 guidance that also exceeds analysts’ expectations. The Irvine, Calif.–based maker of noninvasive patient monitoring technologies and sensors reported profits of $70.7 million, or $1.21 per share, on sales of $295.1 million for the three months ended Jan. 2, 2021, boosting […]
12 surgical robotics companies you need to know
Surgical robotics remains a hot area in medtech — even as it faces headwinds from the COVID-19 pandemic. Intuitive Surgical (NSDQ:ISRG) pioneered robotic surgery through the early 2000s and remains the dominant player, but major companies including Medtronic (NYSE:MDT) and Johnson & Johnson (NYSE:JNJ) have big plans to enter the space and compete. Meanwhile, Stryker (NYSE:SYK) has built a […]
Former Verb Surgical CEO has a medtech SPAC, planning a $175M IPO
A group of medical device industry insiders — including former Verb Surgical and Volcano Corp. CEO Scott Huennekens — is planning a $175 million IPO for a special purpose acquisition company (SPAC). Los Angeles–based VIDA FLaSH Acquisitions filed a form S-1 with the U.S. Securities and Exchange Commission on Feb. 18 for a proposed IPO […]